CIBC Private Wealth Group
CMPX icon

CIBC Private Wealth Group’s Compass Therapeutics CMPX Stock Holding History

CIBC Private Wealth Group’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$204 Buy
+38
New +$175 ﹤0.01% 3210

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIBC Private Wealth Group's CMPX Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Compass Therapeutics (CMPX) in Q4 2025: 38 shares worth $204. The stake represents ﹤0.01% of the portfolio and ranks #3210 among its holdings.

173 funds tracked by Wall St. Rank hold CMPX as of Q4 2025.

  • CIBC Private Wealth Group held 38 shares of Compass Therapeutics worth $204 as of Q4 2025.
  • Compass Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • Compass Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3210 holding.
  • 173 funds tracked by Wall St. Rank held Compass Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.